Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?

por McCartney, Amelia, Di Leo, Angelo, Malorni, Luca
Publicado 2018

Role of lapatinib in the first-line treatment of patients with metastatic breast cancer

por Oakman, Catherine, Pestrin, Marta, Zafarana, Elena, Cantisani, Egidia, Di Leo, Angelo
Publicado 2010

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

por Curigliano, Giuseppe, Criscitiello, Carmen, Andrè, Fabrice, Colleoni, Marco, Di Leo, Angelo
Publicado 2013

Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer

por Oakman, Catherine, Pestrin, Marta, Bessi, Silvia, Galardi, Francesca, Di Leo, Angelo
Publicado 2010

Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

por Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Publicado 2015

Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer

por Oakman, Catherine, Bessi, Silvia, Zafarana, Elena, Galardi, Francesca, Biganzoli, Laura, Di Leo, Angelo
Publicado 2009

A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer

por Turner, Natalie, Forcato, Mattia, Nuzzo, Simona, Malorni, Luca, Bicciato, Silvio, Di Leo, Angelo
Publicado 2015

The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

por De Santo, Irene, McCartney, Amelia, Migliaccio, Ilenia, Di Leo, Angelo, Malorni, Luca
Publicado 2019

Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?

por Turner, Natalie, Pestrin, Marta, Galardi, Francesca, De Luca, Francesca, Malorni, Luca, Di Leo, Angelo
Publicado 2014

Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?

por Rossi, Lorenzo, McCartney, Amelia, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo
Publicado 2018

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in pati...

por Del Re, Marzia, Michelucci, Angela, Di Leo, Angelo, Cantore, Maurizio, Bordonaro, Roberto, Simi, Paolo, Danesi, Romano
Publicado 2015

The role of abemaciclib in treatment of advanced breast cancer

por McCartney, Amelia, Moretti, Erica, Sanna, Giuseppina, Pestrin, Marta, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo
Publicado 2018

Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

por McCartney, Amelia, Vignoli, Alessia, Tenori, Leonardo, Fornier, Monica, Rossi, Lorenzo, Risi, Emanuela, Luchinat, Claudio, Biganzoli, Laura, Di Leo, Angelo
Publicado 2019

A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer

por Robertson, John F. R., Jiang, Zefei, Di Leo, Angelo, Ohno, Shinji, Pritchard, Kathleen I., Ellis, Matthew, Bradbury, Ian, Campbell, Christine
Publicado 2019

Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer

por Migliaccio, Ilenia, Leo, Angela, Galardi, Francesca, Guarducci, Cristina, Fusco, Giulio Maria, Benelli, Matteo, Di Leo, Angelo, Biganzoli, Laura, Malorni, Luca
Publicado 2021

Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing

por Salvianti, Francesca, Rotunno, Giada, Galardi, Francesca, De Luca, Francesca, Pestrin, Marta, Vannucchi, Alessandro Maria, Di Leo, Angelo, Pazzagli, Mario, Pinzani, Pamela
Publicado 2015

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

por Galardi, Francesca, De Luca, Francesca, Romagnoli, Dario, Biagioni, Chiara, Moretti, Erica, Biganzoli, Laura, Di Leo, Angelo, Migliaccio, Ilenia, Malorni, Luca, Benelli, Matteo
Publicado 2020

The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study

por Stebbing, Justin, Payne, Rachel, Reise, Justine, Frampton, Adam E., Avery, Miranda, Woodley, Laura, Di Leo, Angelo, Pestrin, Marta, Krell, Jonathan, Coombes, R. Charles
Publicado 2013

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

por Robertson, John F. R., Di Leo, Angelo, Johnston, Stephen, Chia, Stephen, Bliss, Judith M., Paridaens, Robert J., Lichfield, Jasmine, Bradbury, Ian, Campbell, Christine
Publicado 2021

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

por Pelizzari, Giacomo, Arpino, Grazia, Biganzoli, Laura, Cinieri, Saverio, De Laurentiis, Michelino, Del Mastro, Lucia, Di Leo, Angelo, Gori, Stefania, Guarneri, Valentina, Marchetti, Paolo, Puglisi, Fabio
Publicado 2018